(EL) Estee Lauder Companies - Overview
Stock: Skincare, Makeup, Fragrance, Haircare, Tools
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.77% |
| Yield on Cost 5y | 0.59% |
| Yield CAGR 5y | -10.58% |
| Payout Consistency | 96.6% |
| Payout Ratio | 83.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 42.6% |
| Relative Tail Risk | -13.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.93 |
| Alpha | 20.17 |
| Character TTM | |
|---|---|
| Beta | 1.405 |
| Beta Downside | 1.668 |
| Drawdowns 3y | |
|---|---|
| Max DD | 80.00% |
| CAGR/Max DD | -0.27 |
Description: EL Estee Lauder Companies December 17, 2025
The Estée Lauder Companies (NYSE: EL) designs, manufactures, markets, and sells prestige skin-care, makeup, fragrance, and hair-care products worldwide, operating through a mix of department stores, specialty retailers, e-commerce platforms, and direct-to-consumer channels.
Its portfolio spans 25+ brands-including La Mer, Jo Malone London, Tom Ford, Clinique, M·A·C, The Ordinary, Aveda, and Too Faced-covering the full spectrum of personal-care categories from moisturizers and serums to perfumes and styling products.
Distribution is highly diversified: high-end department stores and perfumeries, duty-free outlets, upscale salons and spas, as well as growing online pure-player sites and the company’s own e-commerce portals.
Key recent metrics (FY 2023) show net sales of roughly $17.7 billion, a 9 % year-over-year increase driven largely by a 22 % rise in Asia-Pacific sales, and adjusted EPS of $6.80, reflecting strong margin expansion in the digital channel.
Sector-wide, the prestige beauty market is buoyed by rising consumer spending on premium personal-care, accelerated digital adoption, and a shift toward “clean” and “inclusive” product narratives; however, macro-level risks include inflation-driven discretionary cutbacks and currency volatility in emerging markets.
For a deeper, data-driven valuation framework, you may find ValueRay’s analyst tools worth a look.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: -930.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.85 > 1.0 |
| NWC/Revenue: 11.29% < 20% (prev 11.19%; Δ 0.10% < -1%) |
| CFO/TA 0.08 > 3% & CFO 1.60b > Net Income -930.0m |
| Net Debt (7.20b) to EBITDA (451.0m): 15.97 < 3 |
| Current Ratio: 1.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (363.3m) vs 12m ago 1.03% < -2% |
| Gross Margin: 74.19% > 18% (prev 0.72%; Δ 7346 % > 0.5%) |
| Asset Turnover: 71.06% > 50% (prev 72.48%; Δ -1.42% > 0%) |
| Interest Coverage Ratio: -0.96 > 6 (EBITDA TTM 451.0m / Interest Expense TTM 398.0m) |
Altman Z'' 3.09
| A: 0.08 (Total Current Assets 6.71b - Total Current Liabilities 5.08b) / Total Assets 19.33b |
| B: 0.60 (Retained Earnings 11.59b / Total Assets 19.33b) |
| C: -0.02 (EBIT TTM -381.0m / Avg Total Assets 20.32b) |
| D: 0.68 (Book Value of Equity 10.46b / Total Liabilities 15.44b) |
| Altman-Z'' Score: 3.09 = A |
Beneish M -3.28
| DSRI: 1.02 (Receivables 1.88b/1.98b, Revenue 14.44b/15.45b) |
| GMI: 0.97 (GM 74.19% / 72.29%) |
| AQI: 0.90 (AQ_t 0.37 / AQ_t-1 0.42) |
| SGI: 0.93 (Revenue 14.44b / 15.45b) |
| TATA: -0.13 (NI -930.0m - CFO 1.60b) / TA 19.33b) |
| Beneish M-Score: -3.28 (Cap -4..+1) = AA |
What is the price of EL shares?
Over the past week, the price has changed by +2.04%, over one month by +11.24%, over three months by +27.83% and over the past year by +46.02%.
Is EL a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 23
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the EL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 109.8 | -7.6% |
| Analysts Target Price | 109.8 | -7.6% |
| ValueRay Target Price | 121.9 | 2.6% |
EL Fundamental Data Overview January 31, 2026
P/S = 2.8757
P/B = 10.6728
P/EG = 3.5737
Revenue TTM = 14.44b USD
EBIT TTM = -381.0m USD
EBITDA TTM = 451.0m USD
Long Term Debt = 7.32b USD (from longTermDebt, last quarter)
Short Term Debt = 418.0m USD (from shortTermDebt, last quarter)
Debt = 9.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.20b USD (from netDebt column, last quarter)
Enterprise Value = 48.75b USD (41.54b + Debt 9.42b - CCE 2.22b)
Interest Coverage Ratio = -0.96 (Ebit TTM -381.0m / Interest Expense TTM 398.0m)
EV/FCF = 46.65x (Enterprise Value 48.75b / FCF TTM 1.04b)
FCF Yield = 2.14% (FCF TTM 1.04b / Enterprise Value 48.75b)
FCF Margin = 7.24% (FCF TTM 1.04b / Revenue TTM 14.44b)
Net Margin = -6.44% (Net Income TTM -930.0m / Revenue TTM 14.44b)
Gross Margin = 74.19% ((Revenue TTM 14.44b - Cost of Revenue TTM 3.73b) / Revenue TTM)
Gross Margin QoQ = 73.37% (prev 71.97%)
Tobins Q-Ratio = 2.52 (Enterprise Value 48.75b / Total Assets 19.33b)
Interest Expense / Debt = 0.91% (Interest Expense 86.0m / Debt 9.42b)
Taxrate = 21.0% (US default 21%)
NOPAT = -301.0m (EBIT -381.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.32 (Total Current Assets 6.71b / Total Current Liabilities 5.08b)
Debt / Equity = 2.42 (Debt 9.42b / totalStockholderEquity, last quarter 3.89b)
Debt / EBITDA = 15.97 (Net Debt 7.20b / EBITDA 451.0m)
Debt / FCF = 6.89 (Net Debt 7.20b / FCF TTM 1.04b)
Total Stockholder Equity = 4.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -4.58% (Net Income -930.0m / Total Assets 19.33b)
RoE = -22.87% (Net Income TTM -930.0m / Total Stockholder Equity 4.07b)
RoCE = -3.35% (EBIT -381.0m / Capital Employed (Equity 4.07b + L.T.Debt 7.32b))
RoIC = -2.65% (negative operating profit) (NOPAT -301.0m / Invested Capital 11.37b)
WACC = 9.17% (E(41.54b)/V(50.96b) * Re(11.09%) + D(9.42b)/V(50.96b) * Rd(0.91%) * (1-Tc(0.21)))
Discount Rate = 11.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 0.46%
[DCF Debug] Terminal Value 65.09% ; FCFF base≈1.16b ; Y1≈761.6m ; Y5≈347.5m
Fair Price DCF = N/A (negative equity: EV 5.65b - Net Debt 7.20b = -1.56b; debt exceeds intrinsic value)
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -58.14 | EPS CAGR: -61.50% | SUE: -4.0 | # QB: 0
Revenue Correlation: -60.55 | Revenue CAGR: -11.65% | SUE: 0.05 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.74 | Chg30d=+0.003 | Revisions Net=+3 | Analysts=19
EPS current Year (2026-06-30): EPS=2.17 | Chg30d=+0.012 | Revisions Net=+8 | Growth EPS=+43.7% | Growth Revenue=+4.4%
EPS next Year (2027-06-30): EPS=2.94 | Chg30d=+0.013 | Revisions Net=+7 | Growth EPS=+35.6% | Growth Revenue=+3.9%